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Unusual clinical course
Isopropanol toxicity is the most common reported toxic alcohol ingestion in the United States and is well known
to emergency physicians. Most toxicities result from unintentional ingestion of rubbing alcohol; however, an
under-recognized mechanism of unintentional toxicity is transdermal absorption. Additionally, hemodialysis
eﬀectively removes isopropanol and its metabolites from circulation, so that in patients receiving regular hemodialysis, the manifestation of toxicity can be delayed.
A 67-year-old woman with end-stage renal disease secondary to insulin-dependent type II diabetes on onceweekly hemodialysis presented to the Emergency Department via the Emergency Medical Service with acute
encephalopathy, severe hypoglycemia, and hypothermia. Her daughter found her confused and lethargic, smelling of acetone, and with a bottle of rubbing alcohol in her hand. The patient had been topically applying large
quantities of rubbing alcohol for several months as a home remedy for cramps and adamantly denied any oral
ingestion. She had missed several hemodialysis appointments over the previous month. Upon arrival, the patient was confused, profoundly hypoglycemic, and hypothermic. Additional laboratory examination revealed
an elevated plasma osmolality, osmolar gap, isopropanol level, and acetone level. She was treated supportively
with glucose-containing ﬂuids and external warming and was admitted to the Intensive Care Unit. Hemodialysis
was resumed, and the patient was discharged 3 days after admission with stable blood glucose, regular body
temperature, and baseline mental status.
Our report is unique as it presents both an under-recognized mechanism of isopropanol toxicity (transdermal
absorption) and an uncommon presentation of chronic exposure with manifestations of toxicity delayed by
regular hemodialysis.
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Isopropanol (also known as isopropyl alcohol or 2-propanol) is a
potent toxic alcohol which annually accounts for the most commonly reported toxic alcohol ingestion in the United States [1].
It is a clear, colorless liquid with an aromatic odor, resembling
acetone [1,2]. It is found in many common household products,
most notably rubbing alcohol, which commonly contains up
to 70% isopropanol [2]. Other products containing isopropanol include hand sanitizers, paint thinners, detergents, jewelry cleaners, and skin/hair products [2]. Most events of toxicity
are unintentional ingestions and occur in children as the liquid is clear, resembles water, and can be easily accessible [3].
However, some patients have ingested isopropanol abusively
as an inexpensive ethanol substitute to achieve inebriation [1].
Unintentional and intentional ingestions of isopropanol are
common presentations to the Emergency Department (ED) in
the United States; however, there have been few cases reported on unintentional toxicity via transdermal absorption of the
toxic alcohol [4,5]. A common yet ill-advised home remedy for
various ailments such as cramps, neuropathy, bug bites, and
rashes is the topical application of rubbing alcohol. Patients
have been reported to apply it directly or soak absorbent materials such as cotton balls, pads, gauze, or towels in the alcohol
and apply it to their skin for signiﬁcant periods of time [4-9].
If applied in large amounts such as in these cases, transdermal absorption and inhalation of the substance have resulted in clinically signiﬁcant toxicity. However, studies in rabbits
suggest that inhalation plays a much smaller role in the development of toxicity relative to transdermal absorption [10].
We present a unique case of a patient who repeatedly applied
large doses of isopropanol to her skin as a home remedy and
developed unintentional isopropanol toxicity via transdermal
absorption, exacerbated by missed hemodialysis. The symptoms of toxicity in this patient were delayed because she received hemodialysis once weekly for end-stage renal disease,
which would remove the toxic metabolites of isopropanol from
circulation, and did not become clinically apparent until dialysis was missed. This patient’s toxicity likely contributed to the
development of severe hypoglycemia and altered mental status, resulting in the admission to the Intensive Care Unit (ICU).

.L^P =P[Z]_
A 67-year-old woman presented to the ED via the Emergency
Medical Service (EMS) with acute encephalopathy, severe hypoglycemia, and hypothermia, with a last known normal status
5 h prior to arrival. She had a past medical history of nonalcoholic steatohepatitis (NASH) cirrhosis, gastric antral vascular ectasia syndrome, hypothyroidism, insulin-dependent type
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2 diabetes mellitus, hypertension, hyperlipidemia, essential
tremor, and end-stage renal disease, with dialysis treatment
on Saturdays. Her home medications included levothyroxine
(200 mcg p.o. daily), furosemide (80 mg p.o. b.i.d.), nifedipine
(30 mg p.o. b.i.d.), propranolol hydrochloride extended-release
(120 mg p.o. daily), doxepin (25 mg p.o. daily), gabapentin
(300 mg p.o. 3 times weekly), atorvastatin (40 mg p.o. daily),
colestipol (3 g p.o. b.i.d.), pantoprazole (40 mg p.o. b.i.d.), and
subcutaneous insulin (glargine 45 units daily in AM; lispro 10
units b.i.d., in AM and PM, plus sliding scale with meals). She
was a former smoker and denied any history of alcohol or illicit drug use. The patient was found by her daughter lying on
the couch, lethargic, confused, with breath smelling of acetone,
and with a bottle of rubbing alcohol (isopropanol) in her hand.
At the time, the patient was confused but adamant that she
had not consumed the alcohol. The patient had been applying
rubbing alcohol topically to her legs, chest, arms, and neck for
several months to treat cramps. She would then use a heating
pad after application. Her daughter stated that over the past
month, the patient had been becoming more confused with
breath that smelled of “nail polish remover”. The patient had
additionally missed several dialysis treatments throughout the
past month due to an illness in her husband. Additionally, she
had diﬃculty maintaining a stable blood glucose level, with
large ﬂuctuations between hyper- and hypoglycemia, as well
as diﬃculty focusing her vision over the past several weeks.
The patient had not eaten anything all day on the day of presentation and could not recall how much insulin she took.
Upon arrival to the ED, the patient was confused, hemodynamically stable, hypothermic with a rectal temperature of 34.4°C,
and hypoglycemic with a blood glucose level of 66. The initial
blood glucose was 33 per the EMS, and the patient was given
intravenous (i.v.) 10% dextrose (D10) and glucose en route.
The patient was administered an additional bolus of D10 and
placed on a Bear-hugger to correct the hypoglycemia and hypothermia, respectively. On initial examination, the patient was
alert and oriented with a Glasgow Coma Scale of 14, was in
no acute distress, and had an intact airway, with no labored
breathing, abdominal tenderness, or focal neurological deﬁcits.
Electrocardiogram (ECG) revealed sinus bradycardia. Laboratory
workup revealed elevated plasma osmolality (330 mOsm/kg),
plasma acetone (116 mg/dL), plasma isopropanol (29 mg/dL),
and a calculated serum osmolar gap of 23.8 mOsm/kg. On repeat laboratory testing, the patient continued to have hypoglycemia and was placed on an i.v. D10 drip at 75 mL/h. Poison
control was contacted and recommended supportive therapy,
including i.v. ﬂuids and management of hypoglycemia. Repeat
laboratory testing 3 h later revealed a plasma isopropanol level of 10 mg/dL and acetone level of 148 mg/dL. The patient
was then admitted to the ICU for management of hypoglycemia, hypothermia, and isopropanol toxicity. The Nephrology
Department was consulted for hemodialysis.
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On day 2 of admission, hemodialysis was resumed, the D10
drip was continued at 75 mL/h, and oral intake was encouraged
while insulin was held. Insulin was resumed as the patient’s
blood glucose level was corrected. The Medical Toxicology
Department was consulted for evaluation of the patient at bedside, and recommended continued supportive therapy. The patient’s mental status and hypothermia improved within 24 h
of admission with glycemic normalization, allowing for discontinuation of the Bear-hugger and i.v. D10 drip and transfer to
the general medical ﬂoor. Post-hemodialysis laboratory examinations included electrolyte studies (which did not reveal any
signiﬁcant abnormalities) but did not include a repeat alcohol
panel given the patient’s improved mental status.
The patient was discharged from the hospital on day 3 of admission with baseline mental status, stable blood glucose, an adjusted home subcutaneous insulin regimen (glargine 25 units daily
in AM [from 45 units], lispro 5 units b.i.d., in AM and PM [from
10 units], plus sliding scale), instructions to skip short-acting
insulin if patient does not eat, a resumed once-weekly dialysis
regimen, and counseling regarding safe use of rubbing alcohol.
There were no complications during management of this patient.

Discussion
This report highlights an interesting case of a patient who
developed clinically signiﬁcant isopropanol toxicity that was
likely via transdermal absorption given the thin nature of her
skin, large surface area, and frequency in which she was applying it. The toxicity ultimately resulted in an altered mental
status, contributing to profound hypoglycemia and hypothermia, necessitating her admission to the ICU. This patient’s presentation is especially unique as her symptoms of toxicity did
not become apparent until after weekly dialysis was missed.
This patient’s hypoglycemia was likely the result of fasting
with inappropriate insulin use, although isopropanol toxicity can result in hypoglycemia as the metabolism of the alcohol by hepatic alcohol dehydrogenase increases the NADH/
NAD+ ratio, inhibiting gluconeogenesis [2]. Nevertheless, her
altered mental status likely contributed to this inappropriate
use. Additionally, gastrointestinal irritation, secondary to isopropanol and its metabolite, acetone, may have resulted in
poor appetite. Similarly, although severe toxicities can result
in hypothermia, this patient’s low body temperature was likely the result of her hypoglycemia; however, both hypoglycemia and hypothermia were indirectly related to isopropanol
toxicity in this patient [3].
This case also reveals important key clinical and diagnostic features of isopropanol toxicity. Upon arrival, this patient
showed signs of mental status depression with an accompanying acetonic odor, a clinical presentation that ought to cue
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the physician to consider isopropanol toxicity as a diagnosis.
Hallmark manifestations of toxicity include inebriation, central
nervous system (CNS) depression, and gastric irritation which
can result in hemorrhage [1,2]. Coma, respiratory depression,
hypotension, renal failure, and rhabdomyolysis can be seen in
severe cases [1,2]. The patient’s laboratory ﬁndings of an elevated osmolar gap and ketonemia without acidosis were also
hallmark diagnostic clues [11]. Unlike the other toxic alcohols
(methanol and ethylene glycol), isopropanol does not cause
acidosis. It is metabolized to acetone by hepatic alcohol dehydrogenase, which does not cause acidosis, although it can
contribute to some level of CNS depression [2]. Acetone was
once thought to be a primary contributor to CNS depression
because it is metabolized from isopropanol; however, several case studies have reported improving mental status in the
setting of rising acetone levels (as also seen in our patient),
which would not be expected if it was a major CNS depressant [12-15]. These studies suggest that isopropanol itself is
the primary CNS depressant in the setting of toxicity, rather
than acetone which likely plays a less signiﬁcant role.
Isopropanol follows ﬁrst order kinetics and has a half-life between 2.5 and 8 h [16-18]. Given its metabolism by hepatic alcohol dehydrogenase, this can be prolonged by hepatic disease, as in our patient with NASH cirrhosis. It has been shown
that hepatic alcohol dehydrogenase activity decreases with the
severity of hepatic dysfunction [19]. However, the laboratory
workup in our patient at 3 h revealed a decreasing plasma isopropanol level and increasing plasma acetone level, suggestive
of hepatic metabolism. Its half-life can also be prolonged by renal disease (as in our patient), as it has been reported that up
to 20% of the absorbed dose of isopropanol is renally excreted, unmetabolized [12]. Acetone, its metabolite, has a slower
half-life, estimated to be between 7 and 24 h [17,18]. This can
be prolonged by renal disease, as it is primarily renally excreted
with some additional respiratory excretion, resulting in our patient’s distinct acetonic breath and patient’s presentation after
missed dialysis [3]. However, acetone can be metabolized via
alternative metabolic pathways in the setting of renal failure
because it is a ketone body and can be metabolized as such.
The treatment of isopropanol toxicity is supportive with the
removal of the oﬀending agent, i.v. hydration, and correction
of other abnormalities, such as the hypoglycemia and hypothermia in our patient [1,2]. Alcohol dehydrogenase inhibitors
(eg, fomepizole) should not be used because they would delay
the metabolism of isopropanol and prolong the symptoms of
toxicity [2]. Hemodialysis is indicated in severe, life-threatening poisonings, toxicity that is refractory to supportive therapy, and isopropanol levels greater than 400 mg/dL [2,3,6].
The ﬁndings of this report are consistent with previous case
reports regarding the development of toxicity from topically
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applied rubbing alcohol [4-9]. In these previously published
cases, the toxicity was unintentional, as the adult patients
were pursuing home remedies for their various symptoms.
Additionally, as transdermal absorption is a slow process, the
development of toxicity requires prolonged exposure, as seen
in our case [5,10,20]. These ﬁndings should raise the awareness of ED physicians to consider transdermal absorption as
a possible mechanism of exposure in patients presenting with
isopropanol toxicity. The results of the present case are also
consistent with previous reports, as toxicity resolved quickly
with supportive therapy and removal of oﬀending agent [4,5].
These previous reports also note the possible potentiation
of toxicity by inhalation of fumes from the rubbing alcohol.
However, the present study is limited by its inability to determine to what degree the inhalation of the fumes played in
developing toxicity.

This study reveals the need for future research to determine
the doses of transdermal isopropanol exposure that result in
toxicity, as well as the need for public education on the appropriate indications and safe uses of the topical application
of rubbing alcohol.

Conclusions
Our report is unique as it presents both an under-recognized
mechanism of isopropanol toxicity (transdermal absorption)
and an uncommon presentation of chronic exposure with
manifestations of toxicity delayed by regular hemodialysis.
Transdermal absorption may account for more presentations
of isopropanol toxicity in the ED than currently recognized.
This report highlights the need for increased awareness by
ED physicians of this mechanism of toxicity and public education on the appropriate indications and safe uses of topical
application of the alcohol.

=PQP]PYNP^%
1. Ashurst JV, Nappe TM. Isopropanol toxicity. [Updated 2021 Jun 26]. In:
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
Available from: https://www.ncbi.nlm.nih.gov/books/NBK493181/

10. Martinez TT, Jaeger RW, deCastro FJ, et al. A comparison of the absorption
and metabolism of isopropyl alcohol by oral, dermal and inhalation routes.
Vet Hum Toxicol. 1986;28(3):233-36

2. Cohen JP, Quan D. Alcohols. In: Tintinalli JE, Ma O, Yealy DM, et al eds.
Tintinalli’s Emergency Medicine: A comprehensive study guide, 9e. McGraw
Hill; 2020. Available from: https://accessemergencymedicine.mhmedical.
com/content.aspx?bookid=2353&sectionid=220744565

11. Sarai M, Tejani AM, Chan AH, et al. Magnesium for alcohol withdrawal.
Cochrane Database Syst Rev. 2013;(6):CD008358

3. Saughter RJ, Mason RW, Beasley DM, et al. Isopropanol poisoning. Clin
Toxicol (Phila). 2014;52(5):470-78

13. Blanchet B, Charachon A, Lukat S, et al. A case of mixed intoxication with
isopropyl alcohol and propanol-1 after ingestion of a topical antiseptic solution. Clin Toxicol (Phila). 2007;45(6):701-4

4. Wolfshohl JA, Jenkins DA, Phillips TM. A case of toxic transdermal absorption of isopropyl alcohol with falsely elevated creatinine. Am J Emerg Med.
2021;377:e5-377
5. Leeper SC, Almatari AL, Ingram JD, Ferslew KE. Topical absorption of isopropyl alcohol induced cardiac and neurologic deﬁcits in an adult female
with intact skin. Vet Hum Toxicol. 2000;42(1):15-17
6. Garrison RF. Acute poisoning from use of isopropyl alcohol in tepid sponging. JAMA. 1953;152(4):317-18
7. Senz EH, Goldfarb DL. Coma in a child following use of isopropyl alcohol in
sponging. J Pediatr. 1958;53(3):322-23

12. Gaudet MP, Fraser GL. Isopropanol ingestion: case report with pharmacokinetic analysis. Am J Emerg Med. 1989;7(3):297-99

14. Mydler TT, Wasserman GS, Watson WA, Knapp JF. Two-week-old infant with
isopropanol intoxication. Pediatr Emerg Care. 1993;9(3):146-48
15. Dua SL. Letter: Peritoneal dialysis for isopropyl alcohol poisoning. JAMA.
1974;230(1):35
16. Daniel DR, McAnalley BH, Garriott JC. Isopropyl alcohol metabolism after
acute intoxication in humans. J Anal Toxicol. 1981;5(3):110-12
17. Natowicz M, Donahue J, Gorman L, et al. Pharmacokinetic analysis of a case
of isopropanol intoxication. Clin Chem. 1985;31(2):326-28

8. Wise, JR. Alcohol sponge baths. N Engl J Med. 1969;280(15):840

18. Jones AW. Elimination half-life of acetone in humans: Case reports and review of the literature. J Anal Toxicol. 2000;24(1):8-10

9. McFadden SW, Haddow JE. Coma produced by topical application of isopropanol. Pediatrics. 1969;43(4):622-23

19. Vidal F, Perez J, Morancho J, et al. Hepatic alcohol dehydrogenase activity in
alcoholic subjects with and without liver disease. Gut. 1990;31(6):707-11
20. Dyer S, Mycyk MB, Ahrens WR, Zell-Kanter M. Hemorrhagic gastritis from
topical isopropanol exposure. Ann Pharmacother. 2002;36(11):1733-35

This work is licensed under Creative Common AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)

e934529-4

Indexed in: [PMC] [PubMed] [Emerging Sources Citation Index (ESCI)]
[Web of Science by Clarivate]

